MedTrace Logo

Clinical Evaluation of Two Daily Wear Silicon Hydrogel Contact Lens

NCT02354924 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-04-14

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to demonstrate that the VISCO (Olifilcon A) soft contact lens could be prescribed as a supportive care for myopic persons.

Conditions

  • Myopia

Interventions

DEVICE

Biofinity soft contact lens

Biofinity soft contact lens on two eyes and follow up for 3 months (90 days). It is necessary to remove contact lenses every day and replace after 30 days.

DEVICE

Visco soft contact lens

Viso soft contact lens on two eyes and follow up for 3 months (90 days). It is necessary to remove contact lenses every day and replace after 30 days.

Sponsors & Collaborators

  • Visco Vision Inc.

    lead INDUSTRY

Principal Investigators

  • Huey Chuan Cheng, MD. MS · Mackey Memorial Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2013-11-30
Completion
2013-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02354924 on ClinicalTrials.gov